Get the Daily Brief
Latest Biotech News
Innovative Biochar Treatment Alleviates Soil Heavy Metal Toxicity in Agriculture
Researchers in China have developed a phosphorus-modified biochar derived from apple tree branches that effectively reduces heavy metal contamination in soils and enhances crop safety. This novel...
Genmab’s $8 Billion Merus Acquisition Expands Bispecific Antibody Pipeline
Genmab has agreed to acquire Merus for approximately $8 billion, securing full ownership of Merus’ promising bispecific antibody therapeutic petosemtamab, targeting head and neck cancer. This...
New Biotech Aerska Secures $21 Million to Deliver RNAi Drugs to Brain
Dublin-based startup Aerska launched with a $21 million seed funding round to develop technology that transports RNA interference (RNAi) therapeutics across the blood-brain barrier. This addresses...
Direct-to-Patient Pharma Platforms Expand Access Amid Pricing Initiatives
Pharmaceutical companies including AstraZeneca and Boehringer Ingelheim, along with new entrants, have launched direct-to-patient prescription programs in the U.S. to improve medication access and...
NRG Oncology Trials Showcase Advances in Cancer Treatment Effectiveness
Recent NRG Oncology studies reveal significant improvements in cancer treatment outcomes across multiple cancers. A Phase II trial combining proton therapy with immunotherapy showed promising...
Ansa Biotechnologies Closes $54.4 Million Series B to Scale DNA Manufacturing
California-based Ansa Biotechnologies secured $54.4 million in Series B funding led by Cerberus Ventures to expand U.S.-based enzymatic DNA synthesis capacity. The company’s innovative DNA...
Advances in AI and Multi-Omics Enable Precision Oncology and Disease Detection
Innovations leveraging artificial intelligence and multi-omics data are revolutionizing precision diagnostics and oncology. Precision oncology firm Predicta Biosciences raised $23.4 million to...
FDA and Drug Pricing Developments Impact Biotech Market and Regulatory Landscape
Significant regulatory and pricing shifts are affecting the biotech and pharmaceutical industries. The FDA faces challenges due to impending government shutdowns, resulting in staffing reductions...
CRISPR and Gene Editing Innovations Propel Therapeutic Advances
The CRISPR gene editing field continues to expand rapidly with novel discoveries and companies capitalizing on recent breakthroughs like CASGEVY. New research elucidates the evolutionary origins...
Innovations in Cancer Immunotherapy and Radiotherapy Improve Patient Survival
Groundbreaking cancer research reveals promising strategies to enhance therapeutic efficacy and patient outcomes. Novel immunotherapeutic approaches, including glioblastoma-targeted biodegradable...
Pfizer and Trump Announce Most-Favored Nation Drug Pricing Deal and Launch Direct-to-Consumer Platform
Pfizer has become the first pharmaceutical company to agree to President Donald Trump's most-favored nation (MFN) drug pricing plan, which aims to lower U.S. drug prices to align with prices in...
Genmab to Acquire Merus for $8 Billion, Expanding Cancer Bispecific Antibody Pipeline
Danish biotech Genmab has agreed to acquire Dutch antibody company Merus for approximately $8 billion, a move that significantly enhances Genmab's oncology pipeline with the addition of...
Enanta Pharmaceuticals Pushes Forward with RSV Therapy Despite Phase 2b Setback
Enanta Pharmaceuticals reported that its oral RSV therapy, zelicapavir, narrowly missed the primary endpoint in a high-risk adult Phase 2b study but demonstrated positive signals in certain...
FDA Faces Operational Challenges Amid Government Shutdown Threat
The U.S. Food and Drug Administration (FDA) is bracing against the impact of a potential federal government shutdown as congressional negotiations stall. The shutdown threatens to furlough or...
Breakthroughs in Spatial Proteomics and High-Dimensional Molecular Analysis
New platforms for spatial proteomics and high-plex protein profiling are expanding the depth and resolution of in situ molecular analysis. Bruker’s GeoMx Discovery Proteome Atlas sets a new...
Cancer Treatment Advances: Novel Therapies and Biomarkers in Development
Cancer research continues to yield innovative therapeutic strategies and prognostic biomarkers. From the identification of dual gene overexpression (CDC20 and UBCH10) linked to poor head and neck...
CRISPR and Gene Editing Technologies Unlock New Mechanistic Insights
Recent studies have advanced understanding of CRISPR-Cas systems and epigenetic editing, enabling more durable gene silencing without permanent DNA alteration. Researchers discovered that...
AI and Machine Learning Enhance Biotech Research and Clinical Applications
Artificial intelligence and machine learning tools are catalyzing breakthroughs across medical diagnostics, drug discovery, and genomics. Cadence Molecular Sciences launched ROCS X, an AI-enabled...
Major Leadership and Corporate Moves Reshape Pharma and Biotech Sectors
Global pharmaceutical companies continue to undergo significant leadership changes and strategic restructurings. GSK announced the departure of CEO Emma Walmsley, marking the end of her nine-year...
Genmab Acquires Merus in $8 Billion Deal to Expand Cancer Pipeline
Genmab announced an $8 billion acquisition of Merus to gain full ownership of the latter's late-stage bispecific antibody, petosemtamab, targeting head and neck cancer. This acquisition aligns...